A Wegovy weight loss pill could soon be a reality after tests showed taking the once-daily oral medication was about as successful at helping people lose weight as its injectable form.
People who were obese or overweight shed an average of 16.6 percent of their body weight following 64 weeks on the 25-milligram GLP-1 pill, Danish drugmaker Novo Nordisk announced Wednesday. A group who took a placebo pill only lost 2.7 percent during the same time frame.
